TLR4 and ischemic stroke: It modulates neuroinflammation via the mitogen-activated protein kinase (MAPK) and Toll-Like Receptor 4 (TLR4) signalling pathways, potentially reducing neuroinflammatory proteins and improving ischaemic stroke outcomes.